Kristine (Xiaohong) She is the Vice President of Operations at Adagene. She has over 20 years of laboratory experience in America’s most renowned laboratories, completing multiple projects in molecular biology and immunology at the labs of University of Chicago, the Genome Center at Stanford University, neurological animal studies at Stanford Palo Alto Veteran’s Hospital, and cloning and functional screening of cDNA libraries at Caltech. Her work has been published in Nature, Science and Biotechnology, among many other notable publications. From these projects, Ms. She has gained extensive operational and management experience, as she often led her coworkers in laboratory and experimental work.
Ms. She received her M.S. from the Institute of Microbiology of the Chinese Academy of Sciences, and her B.S.from Wuhan University.
Yan Li is the Senior Vice President of Bioinformatics and Information Technology at Adagene. She has over 15 years of experience in software development, with more than 10 years focused on the development of informatics software tools for antibody library design and analysis.
Prior to joining Adagene, Ms. Li served as the Senior Software Engineer and Applications Scientist at Abmaxis from November 2001 to May 2006. She developed the software platform for the company’s proprietary AISIM technology, and designed many antibody libraries for in-house pipeline development and business partners. Following the acquisition of Abmaxis by Merck & Co, Ms. Li worked at Merck from May 2006 to December 2010. She received the Merck Award for Excellence in “Innovative Technologies” with the team, and a Special Award for her contribution.
Before her time at Abmaxis, Ms. Li served as a software engineer at Easyware Software, and also as a system analyst and product manager at Singapore Telecom.
Ms. Li received her BSE in information science from East China University of Science and Technology, and her M.B.A. from Santa Clara University with Beta Gamma Sigma honor. She is an inventor of many US and international patents.
JC Xu, M.D., Ph.D., is the Chief Strategy Officer and Head of Regulatory Affairs of Adagene. Dr. Xu has more than 20 years of experience in oncology drug discovery and development and more than 4 years of experience in business development, strategy, and operations in the U.S. biopharmaceutical industry. She previously served as Chief Scientific Officer.
Prior to joining Adagene, Dr. Xu was head of R&ED China Strategy at Celgene (now Bristol Myers Squibb). Prior to that, Dr. Xu was Director of Strategy & Operations at Celgene Quanticel Research and Director of Biology at Quanticel Pharmaceuticals. She was instrumental in the successful acquisition of Quanticel by Celgene. Prior to Quanticel, Dr. Xu worked in leadership roles at a number of biopharmaceutical companies, both large and small, including Pfizer, Amgen, and Corixa.
Dr. Xu received her M.D. from Beijing Medical University (now Peking University Health Science Center) and her Ph.D. in immunology from University of Alabama at Birmingham. She completed her post-doctoral training at DNAX Research Institute (now Merck Palo Alto). She is an inventor of more than 120 issued and pending patents and has published more than 50 articles in peer-reviewed journals.
Mr. Man Kin (Raymond) Tam is the Chief Financial Officer of Adagene. He has over 20 years of management experience in finance and banking across Asia Pacific.
Prior to Adagene, Mr. Tam served as Chief Financial Officer of different corporations including AgenTus Therapeutics, Inc. and China Regenerative Medicine International Limited. Mr. Tam also served as Project Director of Mineralogy Pty Limited and Chief Financial Officer of Resourcehouse Limited. Further, he held various management positions with J.P. Morgan and HSBC from 1999 to 2010.
Mr. Tam is a fellow of CPA Australia, a member of the American Institute of Certified Public Accountants and the Hong Kong Institute of Certified Public Accountants. He is also a CFA and FRM charter-holder. Mr. Tam obtained an Executive Master of Business Administration degree from the University of Western Ontario in Canada in 2005, a Master of Practising Accounting degree from the Monash University in Australia in 2001 and a Bachelor of Civil & Resources Engineering (with First Class Honors) degree from the University of Auckland in New Zealand in 1998.
